JP2024515346A - 立体構造スイッチングナノ構造体 - Google Patents
立体構造スイッチングナノ構造体 Download PDFInfo
- Publication number
- JP2024515346A JP2024515346A JP2023564438A JP2023564438A JP2024515346A JP 2024515346 A JP2024515346 A JP 2024515346A JP 2023564438 A JP2023564438 A JP 2023564438A JP 2023564438 A JP2023564438 A JP 2023564438A JP 2024515346 A JP2024515346 A JP 2024515346A
- Authority
- JP
- Japan
- Prior art keywords
- nanostructure
- coupling
- molecule
- entity
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21169934.3A EP4079330A1 (en) | 2021-04-22 | 2021-04-22 | Conformation switching nanostructures |
| EP21169934.3 | 2021-04-22 | ||
| PCT/EP2022/060737 WO2022223802A1 (en) | 2021-04-22 | 2022-04-22 | Conformation switching nanostructures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515346A true JP2024515346A (ja) | 2024-04-09 |
| JP2024515346A5 JP2024515346A5 (cg-RX-API-DMAC7.html) | 2025-05-01 |
Family
ID=75659780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564438A Pending JP2024515346A (ja) | 2021-04-22 | 2022-04-22 | 立体構造スイッチングナノ構造体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240199763A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4079330A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024515346A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230175241A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117222437A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022223802A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4399528A1 (en) | 2021-09-09 | 2024-07-17 | Nautilus Subsidiary, Inc. | Characterization and localization of protein modifications |
| EP4764494A1 (en) * | 2024-12-20 | 2026-06-24 | Plectonic Biotech GmbH | Conjugates for analyte detection and quantification |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020254684A1 (en) * | 2019-06-21 | 2020-12-24 | Tilibit Nanosystems Gmbh | Conditionally switchable nanostructure |
-
2021
- 2021-04-22 EP EP21169934.3A patent/EP4079330A1/en not_active Withdrawn
-
2022
- 2022-04-22 US US18/287,269 patent/US20240199763A1/en active Pending
- 2022-04-22 EP EP22724742.6A patent/EP4326342A1/en active Pending
- 2022-04-22 JP JP2023564438A patent/JP2024515346A/ja active Pending
- 2022-04-22 KR KR1020237039385A patent/KR20230175241A/ko active Pending
- 2022-04-22 WO PCT/EP2022/060737 patent/WO2022223802A1/en not_active Ceased
- 2022-04-22 CN CN202280030065.3A patent/CN117222437A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020254684A1 (en) * | 2019-06-21 | 2020-12-24 | Tilibit Nanosystems Gmbh | Conditionally switchable nanostructure |
Non-Patent Citations (2)
| Title |
|---|
| NATURE COMMUNICATIONS, vol. 10, JPN6026009215, 2019, pages 1 - 9, ISSN: 0005813181 * |
| NATURE COMMUNICATIONS, vol. 2, JPN6026009212, 2011, pages 1 - 8, ISSN: 0005813182 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240199763A1 (en) | 2024-06-20 |
| EP4326342A1 (en) | 2024-02-28 |
| CN117222437A (zh) | 2023-12-12 |
| KR20230175241A (ko) | 2023-12-29 |
| WO2022223802A1 (en) | 2022-10-27 |
| EP4079330A1 (en) | 2022-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| van der Meel et al. | Next-generation materials for nucleic acid delivery | |
| Jain et al. | Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery | |
| Céspedes et al. | In vivo architectonic stability of fully de novo designed protein-only nanoparticles | |
| US9297013B2 (en) | pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles | |
| Pawar et al. | Current update on transcellular brain drug delivery | |
| He et al. | Peptide-induced self-assembly of therapeutics into a well-defined nanoshell with tumor-triggered shape and charge switch | |
| Serna et al. | Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles | |
| Serrano et al. | DNA-peptide amphiphile nanofibers enhance aptamer function | |
| Tong et al. | Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood–brain barrier and treatment of glioblastoma multiforme | |
| US20190117572A1 (en) | Microfluidic-formulated leukosome compositions and fabrication methods therefor | |
| US20240199763A1 (en) | Conformation switching nanostructures | |
| Shi et al. | Virus mimetic framework DNA as a non-LNP gene carrier for modulated cell endocytosis and apoptosis | |
| CN104395475B (zh) | 基于jcv-病毒样颗粒的新型药物递送系统 | |
| Pottash et al. | Protein-based vehicles for biomimetic RNAi delivery | |
| EP2864345B1 (en) | Particle-nucleic acid conjugates and therapeutic uses related thereto | |
| Xiao et al. | In vivo interactions of nucleic acid nanostructures with cells | |
| Li et al. | Intranuclear delivery of DNA nanostructures via cellular mechanotransduction | |
| Kanwar et al. | Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases | |
| Qian et al. | Recent Progress in Gene Delivery Systems Based on Gemini‐Surfactant | |
| Zhang et al. | Exploring the effect of drug loading on the biological fate of polymer-coated solid nanoparticles | |
| Noble et al. | Folding-mediated DNA delivery by α-helical amphipathic peptides | |
| Covarrubias-Zambrano et al. | Development of a gene delivery system composed of a cell-penetrating peptide and a nontoxic polymer | |
| CN119998457A (zh) | 基于金属纳米颗粒-核酸缀合物的基因载体 | |
| Wang et al. | RNA binding protein as monodisperse carriers for siRNA delivery | |
| Zabel et al. | Lipopeptide delivery of siRNA to the central nervous system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20240220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250421 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250421 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260310 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260414 |